thanks for posting the article. I don’t think CSL will have anything to be concerned about. I do think the article however is a hatchet job on Aegros. Interviewing so called experts who don’t have any clue as to the intimacy of the technology as they are using a different process entirely(Cohn) . The Aegros technology has evolved and testament to this is the additional hyper immune products they can derive from the plasma.
Aegros have some fantastic people (operations, R&d ,scientific advisory) with depth and I am confident this business will succeed.
I am a shareholder in Aegros
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$257.38 |
Change
8.990(3.62%) |
Mkt cap ! $124.6B | |||
| Open | High | Low | Value | Volume |
| $252.00 | $258.31 | $251.10 | $370.9M | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $257.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $257.38 | 3331 | 1 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |